SPECIFIC CONTRACT FOR THE SUPPLY OF THE MONOCLONAL ANTIBODY BEYFORTUS REQUIRED BY THE HEALTH AUTHORITIES OF THE ABRUZZO REGION WITHIN THE DYNAMIC PURCHASING SYSTEM FOR THE SUPPLY OF DRUGS, BLOOD DERIVATIVES, VACCINES, AND CONTRAST MEDIA FOR THE HEALTH AUTHORITIES OF THE ABRUZZO REGION AND OTHER AGGREGATORS

This specific contract tender, managed through a Dynamic Purchasing System (DPS), is for the supply of the monoclonal antibody Beyfortus. The procurement is for the health authorities of the Abruzzo Region and potentially other aggregating bodies. The DPS is designed for the supply of drugs, blood derivatives, vaccines, and contrast media. This tender focuses on Beyfortus, a therapeutic agent likely used for specific medical conditions. The contracting authority is AREACOM AGENZIA REGIONALE DELL'ABRUZZO PER LA COMMITTENZA. The estimated value is EUR 1,610,000.00, divided into two lots for the same product (NIRSEVIMAB). The procedure is restricted, indicating a pre-selected list of suppliers within the DPS. Sanofi was awarded Lot 1.

This is a supplies contract in the general supplies sector. Located in Italy, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 1.6 million.

Published through ANAC (Italy), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the general supplies sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.